n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cognition Disorders in 95 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Little is known about the effect of stimulant use (amphetamines, cocaine, ecstasy) on cognitive functioning in schizophrenia patients." | 3.80 | Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. ( Meijer, CJ; Meijer, JH; van den Brink, W; van der Meer, FJ; Velthorst, E, 2014) |
| " Thus, the current state of research does not allow for the conclusion that long-term use of MDMA affects decision-making behavior in general." | 2.55 | Decision-making in chronic ecstasy users: a systematic review. ( Betzler, F; Romanczuk-Seiferth, N; Viohl, L, 2017) |
| "There is a higher frequency of both psychiatric illness and cognitive impairment among ecstasy users." | 2.43 | [Psychiatric and cognitive long-term effects of ecstasy]. ( Bachs, L; Bramness, JG; Høiseth, G; Løvåsdal, Ø; Titze, TK, 2006) |
| "Conventional wisdom, and even well-reasoned theoretical mechanisms, suggests that the chronic use of psychoactive substances would impair cognitive functioning of individuals." | 2.42 | Cognitive impairment in substance abuse. ( Cellucci, T; Hedt, J; Jarchow, A; Vik, PW, 2004) |
| " The possibility that some of these psychological problems are caused by ecstasy-induced neurotoxicity is supported by preclinical evidence of MDMA-induced neurotoxicity and behavioural deficits, evidence of depleted serotonin in heavy ecstasy users, and by dose-response relationships between the extent of exposure to ecstasy and the severity of cognitive impairments." | 2.41 | Ecstasy (MDMA): a review of its possible persistent psychological effects. ( Morgan, MJ, 2000) |
| " This case report indicates that even non-chronic MDMA use may cause subacute toxic encephalopathy in which the clinical evolution is paralleled by neuroimaging changes in specific cerebral areas." | 1.35 | Hippocampal remodelling after MDMA neurotoxicity: a single case study. ( Amistà, P; Battaglia, M; Bertagnoni, GE; Carollo, C; Costanzo, R; Lupi, A; Martinuzzi, A; Nifosì, F; Perini, G; Toffanin, T; Vestri, A, 2009) |
| "During sleep deprivation, MDMA users, but not controls, became increasingly impulsive, performing more rapidly at the expense of accuracy on tasks of working and short-term memory." | 1.35 | Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users. ( McCann, UD; Ricaurte, GA; Sgambati, FP; Wilson, MJ, 2009) |
| "Additionally, users that met DSM-IV substance use disorder criteria for lifetime MDMA abuse or dependence exhibited a number of additional deficits relative to those who did not meet these criteria." | 1.32 | Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. ( Hanson, KL; Luciana, M, 2004) |
| " To test for a possible dose-response effect, we also performed a median split of 12 moderate MDMA users (22-50 lifetime uses) and 11 heavy users (60-450 uses), and compared these subgroups with non-users." | 1.32 | Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. ( Barry, S; Halpern, JH; Hudson, JI; Pope, HG; Sherwood, AR; Yurgelun-Todd, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.11) | 18.2507 |
| 2000's | 66 (69.47) | 29.6817 |
| 2010's | 27 (28.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, CA | 4 |
| Quednow, BB | 3 |
| Montgomery, C | 8 |
| Parrott, AC | 10 |
| Valverde, O | 1 |
| Rodríguez-Árias, M | 2 |
| Fairclough, SH | 1 |
| McGlone, FP | 1 |
| Fisk, JE | 6 |
| van der Meer, FJ | 1 |
| Meijer, JH | 1 |
| Meijer, CJ | 1 |
| van den Brink, W | 3 |
| Velthorst, E | 1 |
| Pázmány, P | 1 |
| Petschner, P | 1 |
| Ádori, C | 1 |
| Kirilly, E | 1 |
| Andó, DR | 1 |
| Balogh, B | 1 |
| Gyöngyösi, N | 1 |
| Bagdy, G | 1 |
| Ruis, C | 1 |
| Postma, A | 1 |
| Bouvy, W | 1 |
| van der Ham, I | 1 |
| Costa, G | 1 |
| Simola, N | 1 |
| Morelli, M | 1 |
| Wetherell, MA | 1 |
| Garg, A | 1 |
| Kapoor, S | 1 |
| Goel, M | 1 |
| Chopra, S | 1 |
| Chopra, M | 1 |
| Kapoor, A | 1 |
| McCann, UD | 2 |
| Behera, C | 1 |
| Downey, LA | 1 |
| Sands, H | 1 |
| Jones, L | 1 |
| Clow, A | 1 |
| Evans, P | 1 |
| Stalder, T | 1 |
| García-Pardo, MP | 1 |
| Roger-Sánchez, C | 1 |
| Miñarro, J | 1 |
| Aguilar, MA | 1 |
| Betzler, F | 1 |
| Viohl, L | 1 |
| Romanczuk-Seiferth, N | 1 |
| Nifosì, F | 1 |
| Martinuzzi, A | 1 |
| Toffanin, T | 1 |
| Costanzo, R | 1 |
| Vestri, A | 1 |
| Battaglia, M | 1 |
| Bertagnoni, GE | 1 |
| Lupi, A | 1 |
| Amistà, P | 1 |
| Carollo, C | 1 |
| Perini, G | 1 |
| Krebs, TS | 1 |
| Johansen, PØ | 1 |
| Jerome, L | 1 |
| Halpern, JH | 3 |
| Pompili, M | 1 |
| Lester, D | 1 |
| Girardi, P | 1 |
| Tatarelli, R | 1 |
| Wilson, MJ | 1 |
| Sgambati, FP | 1 |
| Ricaurte, GA | 2 |
| Piechatzek, M | 1 |
| Indlekofer, F | 1 |
| Daamen, M | 1 |
| Glasmacher, C | 1 |
| Lieb, R | 1 |
| Pfister, H | 1 |
| Tucha, O | 1 |
| Lange, KW | 1 |
| Wittchen, HU | 1 |
| Schütz, CG | 1 |
| Ayala, ME | 1 |
| Plaza-Zabala, A | 1 |
| Berrendero, F | 1 |
| Suarez, J | 1 |
| Bermudez-Silva, FJ | 1 |
| Fernandez-Espejo, E | 1 |
| Serrano, A | 1 |
| Pavon, FJ | 1 |
| Parsons, LH | 1 |
| De Fonseca, FR | 1 |
| Maldonado, R | 1 |
| Robledo, P | 1 |
| Hadjiefthyvoulou, F | 2 |
| Bridges, N | 2 |
| Dastrup, E | 1 |
| Lees, MN | 1 |
| Bechara, A | 2 |
| Dawson, JD | 1 |
| Rizzo, M | 2 |
| Hanson, KL | 3 |
| Luciana, M | 3 |
| Blagrove, M | 1 |
| Seddon, J | 1 |
| George, S | 1 |
| Stickgold, R | 1 |
| Walker, MP | 1 |
| Jones, KA | 1 |
| Morgan, MJ | 3 |
| Sherwood, AR | 2 |
| Hudson, JI | 2 |
| Gruber, S | 1 |
| Kozin, D | 1 |
| Pope, HG | 2 |
| Kay, C | 1 |
| Harper, DN | 1 |
| Hunt, M | 1 |
| Fogger, SA | 1 |
| Rodgers, J | 1 |
| Buchanan, T | 1 |
| Heffernan, T | 1 |
| Ling, J | 1 |
| Scholey, A | 1 |
| Cheng, L | 1 |
| Wang, SH | 1 |
| Chen, QC | 1 |
| Liao, XM | 1 |
| Hulka, LM | 1 |
| Wagner, M | 2 |
| Preller, KH | 1 |
| Jenni, D | 1 |
| Schaefer, TL | 1 |
| Grace, CE | 1 |
| Braun, AA | 1 |
| Amos-Kroohs, RM | 1 |
| Graham, DL | 1 |
| Skelton, MR | 1 |
| Williams, MT | 1 |
| Vorhees, CV | 1 |
| Fox, HC | 3 |
| McLean, A | 1 |
| Turner, JJ | 3 |
| Rogers, R | 1 |
| Sahakian, BJ | 2 |
| Parrott, A | 1 |
| Cole, JC | 2 |
| Sumnall, HR | 2 |
| Gouzoulis-Mayfrank, E | 4 |
| Thimm, B | 1 |
| Rezk, M | 1 |
| Hensen, G | 1 |
| Daumann, J | 4 |
| Riedel, WJ | 1 |
| Vik, PW | 1 |
| Cellucci, T | 1 |
| Jarchow, A | 1 |
| Hedt, J | 1 |
| Barry, S | 1 |
| Yurgelun-Todd, D | 1 |
| Lyvers, M | 2 |
| Hasking, P | 1 |
| Murphy, P | 1 |
| Wareing, M | 1 |
| Verdejo-García, AJ | 1 |
| López-Torrecillas, F | 1 |
| Aguilar de Arcos, F | 1 |
| Pérez-García, M | 1 |
| Milani, RM | 1 |
| Schifano, F | 1 |
| Newman, RG | 1 |
| Degenhardt, L | 1 |
| Copeland, J | 1 |
| Dillon, P | 1 |
| Thomasius, R | 2 |
| Petersen, KU | 1 |
| Zapletalova, P | 2 |
| Wartberg, L | 2 |
| Zeichner, D | 1 |
| Schmoldt, A | 2 |
| Roiser, JP | 1 |
| Rogers, RD | 2 |
| Casco, C | 1 |
| Forcella, M | 1 |
| Beretta, G | 1 |
| Grieco, A | 1 |
| Campana, G | 1 |
| Dafters, RI | 2 |
| Medina, KL | 1 |
| Shear, PK | 1 |
| Corcoran, K | 1 |
| Kühn, KU | 1 |
| Hoppe, C | 1 |
| Westheide, J | 1 |
| Maier, W | 1 |
| Daum, I | 1 |
| Høiseth, G | 1 |
| Løvåsdal, Ø | 1 |
| Titze, TK | 1 |
| Bramness, JG | 1 |
| Bachs, L | 1 |
| Petersen, K | 1 |
| Buchert, R | 1 |
| Andresen, B | 1 |
| Nebeling, B | 1 |
| Lamers, CT | 1 |
| Ramaekers, JG | 1 |
| Reay, JL | 1 |
| Hamilton, C | 1 |
| Kennedy, DO | 1 |
| Scholey, AB | 1 |
| Baylen, CA | 1 |
| Rosenberg, H | 1 |
| Smith, RM | 1 |
| Tivarus, M | 1 |
| Campbell, HL | 1 |
| Hillier, A | 1 |
| Beversdorf, DQ | 1 |
| Dalley, JW | 1 |
| Lääne, K | 1 |
| Theobald, DE | 1 |
| Peña, Y | 1 |
| Bruce, CC | 1 |
| Huszar, AC | 1 |
| Wojcieszek, M | 1 |
| Everitt, BJ | 1 |
| Robbins, TW | 2 |
| Kalechstein, AD | 1 |
| De La Garza, R | 1 |
| Mahoney, JJ | 1 |
| Fantegrossi, WE | 1 |
| Newton, TF | 1 |
| Fischer, RB | 1 |
| Golding, JF | 1 |
| Groome, DH | 1 |
| Rycroft, N | 1 |
| Denton, Z | 1 |
| Schilt, T | 2 |
| de Win, MM | 2 |
| Koeter, M | 1 |
| Jager, G | 2 |
| Korf, DJ | 1 |
| Schmand, B | 2 |
| Hoshi, R | 1 |
| Mullins, K | 1 |
| Boundy, C | 1 |
| Brignell, C | 1 |
| Piccini, P | 1 |
| Curran, HV | 1 |
| Frenzilli, G | 1 |
| Ferrucci, M | 1 |
| Giorgi, FS | 1 |
| Blandini, F | 1 |
| Nigro, M | 1 |
| Ruggieri, S | 1 |
| Murri, L | 1 |
| Paparelli, A | 1 |
| Fornai, F | 1 |
| Zakzanis, KK | 1 |
| Campbell, Z | 1 |
| Jovanovski, D | 1 |
| Koeter, MW | 1 |
| Ramsey, NF | 1 |
| Yücel, M | 1 |
| Lubman, DI | 1 |
| Solowij, N | 1 |
| Brewer, WJ | 1 |
| Peters, GJ | 1 |
| Kok, G | 1 |
| Abraham, C | 1 |
| Karlsen, SN | 1 |
| Spigset, O | 1 |
| Slørdal, L | 1 |
| de Sola Llopis, S | 1 |
| Miguelez-Pan, M | 1 |
| Peña-Casanova, J | 1 |
| Poudevida, S | 1 |
| Farré, M | 1 |
| Pacifici, R | 1 |
| Böhm, P | 1 |
| Abanades, S | 1 |
| Verdejo García, A | 1 |
| Langohr, K | 1 |
| Zuccaro, P | 1 |
| de la Torre, R | 1 |
| Bedi, G | 1 |
| Redman, J | 1 |
| Sullwold, K | 1 |
| Mueller, PD | 1 |
| Korey, WS | 1 |
| McGuire, P | 1 |
| Kelly, PA | 2 |
| Tuchtenhagen, F | 1 |
| Pelz, S | 1 |
| Becker, S | 1 |
| Kunert, HJ | 1 |
| Fimm, B | 1 |
| Sass, H | 1 |
| Croft, RJ | 1 |
| Mackay, AJ | 1 |
| Mills, AT | 1 |
| Gruzelier, JG | 1 |
| Bhattachary, S | 1 |
| Powell, JH | 1 |
| McFie, L | 1 |
| Fleetwood, H | 1 |
| Robinson, JA | 1 |
| Wagstaff, GF | 1 |
| Krystal, JH | 1 |
| Price, LH | 1 |
| Opsahl, C | 1 |
| Heninger, GR | 1 |
26 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Cognition Disorders
| Article | Year |
|---|---|
MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.
Topics: Brain; Cognition Disorders; Electroencephalography; Functional Neuroimaging; Humans; N-Methyl-3,4-me | 2018 |
Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.
Topics: Amphetamine-Related Disorders; Animals; Cannabinoids; Cannabis; Cognition Disorders; Endocannabinoid | 2013 |
MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
Topics: Amphetamine-Related Disorders; Cognition; Cognition Disorders; Humans; Illicit Drugs; Memory; N-Meth | 2013 |
[The cognitive effects of ecstasy].
Topics: Cerebrovascular Circulation; Circadian Rhythm; Cognition; Cognition Disorders; Endocannabinoids; Fev | 2013 |
Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
Topics: Amphetamine-Related Disorders; Animals; Brain; Cognition; Cognition Disorders; Hallucinogens; Humans | 2015 |
Decision-making in chronic ecstasy users: a systematic review.
Topics: Animals; Cognition Disorders; Decision Making; Humans; Memory Disorders; N-Methyl-3,4-methylenedioxy | 2017 |
Altered states: the clinical effects of Ecstasy.
Topics: 3,4-Methylenedioxyamphetamine; Brain; Clinical Trials as Topic; Cognition Disorders; Hallucinogens; | 2003 |
Cognitive impairment in substance abuse.
Topics: Alcohol Amnestic Disorder; Amphetamines; Central Nervous System Stimulants; Cognition Disorders; Eth | 2004 |
Have Halpern et al. (2004) detected 'residual neuropsychological effects' of MDMA? Not likely.
Topics: Cognition Disorders; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests | 2004 |
Recent trends in the use of "club drugs": an Australian review.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Anesthetics, Dissociative; Australia; Cognition Disorders; | 2005 |
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Topics: Animals; Brain Diseases; Cognition Disorders; Hallucinogens; Humans; Memory Disorders; Mental Disord | 2006 |
[Psychiatric and cognitive long-term effects of ecstasy].
Topics: Animals; Brain; Cognition Disorders; Cross-Sectional Studies; Hallucinogens; Humans; Longitudinal St | 2006 |
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Topics: Affect; Amphetamine-Related Disorders; Brain; Cannabinoids; Cognition Disorders; Drug Interactions; | 2006 |
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Topics: Amphetamine-Related Disorders; Brain; Cannabinoids; Cell Survival; Cognition Disorders; Hallucinogen | 2006 |
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Topics: Affect; Amphetamine-Related Disorders; Brain; Cognition Disorders; Cross-Sectional Studies; Dose-Res | 2006 |
Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
Topics: Amphetamine-Related Disorders; Animals; Brain; Cognition Disorders; Diagnostic Imaging; Disease Mode | 2006 |
A review of the acute subjective effects of MDMA/ecstasy.
Topics: Adolescent; Adult; Aged; Cognition; Cognition Disorders; Emotions; Female; Hallucinogens; Humans; Il | 2006 |
MDMA use and neurocognition: a meta-analytic review.
Topics: Amphetamine-Related Disorders; Attention; Cognition; Cognition Disorders; Hallucinogens; Humans; Lea | 2007 |
The neuropsychology of ecstasy (MDMA) use: a quantitative review.
Topics: Attention; Cognition Disorders; Hallucinogens; Humans; Learning; Memory; N-Methyl-3,4-methylenedioxy | 2007 |
Understanding drug addiction: a neuropsychological perspective.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Analgesics, Opioid; Behavior, Addictive; Central Nervous | 2007 |
Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review.
Topics: Adaptation, Psychological; Amphetamine-Related Disorders; Cognition Disorders; Evidence-Based Medici | 2008 |
The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Topics: Animals; Cognition Disorders; Dose-Response Relationship, Drug; Half-Life; Hallucinogens; Humans; Il | 2008 |
Long term psychiatric and cognitive effects of MDMA use.
Topics: Chronic Disease; Cognition Disorders; Hallucinogens; Humans; Memory Disorders; Mental Recall; N-Meth | 2000 |
Ecstasy (MDMA): a review of its possible persistent psychological effects.
Topics: Affect; Aggression; Animals; Anxiety; Brain; Cognition Disorders; Humans; Memory; N-Methyl-3,4-methy | 2000 |
Investigating the neurocognitive deficits associated with chronic drug misuse.
Topics: Animals; Chronic Disease; Cocaine-Related Disorders; Cognition Disorders; Humans; Marijuana Abuse; N | 2001 |
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.
Topics: Animals; Cognition Disorders; Humans; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Neur | 2002 |
4 trials available for n-methyl-3,4-methylenedioxyamphetamine and Cognition Disorders
| Article | Year |
|---|---|
Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
Topics: Adult; Analysis of Variance; Attention; Central Nervous System Stimulants; Cognition Disorders; Elec | 2013 |
Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
Topics: Adult; Aggression; Alcohol Drinking; Cognition Disorders; Drug Interactions; Family; Female; Humans; | 2005 |
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Cognition Disorders; Decision Making; Depression; Dis | 2006 |
Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
Topics: Adult; Cognition Disorders; Female; Hallucinogens; Humans; Male; Memory, Short-Term; Mental Disorder | 2001 |
65 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Cognition Disorders
| Article | Year |
|---|---|
Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamines; Central Nervous System Stimulants; Cocaine; Cogni | 2014 |
Cognitive disorders after sporadic ecstasy use? A case report.
Topics: Adult; Atrophy; Cognition Disorders; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; | 2015 |
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.
Topics: Animals; Astrocytes; CD11b Antigen; Cognition; Cognition Disorders; Glial Fibrillary Acidic Protein; | 2014 |
Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Topics: Adolescent; Adult; Case-Control Studies; Cognition Disorders; Drug Users; Female; Hallucinogens; Hum | 2015 |
Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cognition Disorders; Female; Hair; Hallucinogens; | 2015 |
Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users.
Topics: Adult; Case-Control Studies; Cognition Disorders; Drug Users; Female; Functional Neuroimaging; Human | 2015 |
Cognitive and behavioural effects induced by social stress plus MDMA administration in mice.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavioral Symptoms; Body Temperature; Cognition | 2017 |
Hippocampal remodelling after MDMA neurotoxicity: a single case study.
Topics: Adolescent; Anticonvulsants; Body Temperature Regulation; Cognition Disorders; Electroencephalograph | 2009 |
Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.
Topics: Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Bias; Cognition Disorders; Comorbidity; | 2009 |
High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use.
Topics: Adult; Cocaine-Related Disorders; Cognition Disorders; Humans; Male; Marijuana Abuse; Memory Disorde | 2007 |
Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.
Topics: Adult; Cognition; Cognition Disorders; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; | 2009 |
Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
Topics: Adult; Alcohol Drinking; Cognition Disorders; Databases, Factual; Executive Function; Female; Humans | 2009 |
Brain serotonin, psychoactive drugs, and effects on reproduction.
Topics: Affect; Amphetamine-Related Disorders; Animals; Biological Clocks; Brain; Cognition Disorders; Depre | 2009 |
Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice.
Topics: Animals; Avoidance Learning; Cognition Disorders; Corpus Striatum; Dopamine Plasma Membrane Transpor | 2010 |
Everyday and prospective memory deficits in ecstasy/polydrug users.
Topics: Cognition; Cognition Disorders; Comprehension; Female; Humans; Illicit Drugs; Male; Memory; Memory D | 2011 |
Risky car following in abstinent users of MDMA.
Topics: Adrenergic Uptake Inhibitors; Adult; Attention; Automobile Driving; Automobiles; Cognition; Cognitio | 2010 |
Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
Topics: Adolescent; Adult; Cognition Disorders; Female; Hallucinogens; Humans; Inhibition, Psychological; Lo | 2010 |
Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
Topics: Adult; Amphetamine-Related Disorders; Cognition; Cognition Disorders; Female; Humans; Illicit Drugs; | 2011 |
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
Topics: Adolescent; Adult; Case-Control Studies; Chronic Disease; Cognition; Cognition Disorders; Confoundin | 2011 |
The effects of binge MDMA on acquisition and reversal learning in a radial-arm maze task.
Topics: Adaptation, Psychological; Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Dis | 2011 |
Update on ecstasy.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Amphetamine-Related Disorders; Anxiety Disorders; Cognitio | 2011 |
'Ecstasy use, by itself, does not result in residual neurotoxicity'- a powerful argument?
Topics: Cognition Disorders; Epidemiologic Factors; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substanc | 2011 |
Moderate noise induced cognition impairment of mice and its underlying mechanisms.
Topics: Acoustic Stimulation; Animals; Auditory Cortex; Avoidance Learning; Behavior, Animal; Cognition Diso | 2011 |
Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine-Related | 2013 |
Self-reports of executive dysfunction in current ecstasy/polydrug Users.
Topics: Adolescent; Adult; Cognition Disorders; Diagnostic Self Evaluation; Drug Users; Executive Function; | 2012 |
Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA.
Topics: Animals; Animals, Newborn; Body Weight; Citalopram; Cognition Disorders; Disease Models, Animal; Fem | 2013 |
Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Topics: Adolescent; Adult; Association Learning; Attention; Cognition Disorders; Decision Making; Female; Ha | 2002 |
Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Topics: Cannabis; Cognition; Cognition Disorders; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methyle | 2003 |
Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole.
Topics: Clinical Trials as Topic; Cognition Disorders; Dose-Response Relationship, Drug; Hallucinogens; Huma | 2003 |
Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Topics: Adult; Analysis of Variance; Cognition Disorders; Female; Hippocampus; Humans; Male; Memory Disorder | 2003 |
Cognitive changes after acute tryptophan depletion: what can they tell us?
Topics: Alzheimer Disease; Cognition Disorders; Depressive Disorder, Major; Human Experimentation; Humans; N | 2004 |
Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
Topics: Adolescent; Adult; Brain; Cognition Disorders; Depression; Diagnostic and Statistical Manual of Ment | 2004 |
Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
Topics: Adolescent; Adult; Cognition Disorders; Female; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedio | 2004 |
Evidence for executive deficits among users of MDMA (Ecstasy).
Topics: Adult; Cognition; Cognition Disorders; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedi | 2004 |
Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
Topics: Adult; Alcoholism; Cocaine-Related Disorders; Cognition Disorders; Female; Humans; Male; Marijuana A | 2005 |
Comment on Soar, et al.'s case study of problems and use of Ecstasy.
Topics: Cognition Disorders; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Ti | 2005 |
Mental disorders in current and former heavy ecstasy (MDMA) users.
Topics: Adult; Amphetamine-Related Disorders; Anxiety Disorders; Cognition Disorders; Cross-Sectional Studie | 2005 |
Neuropsychological function in ecstasy users: a study controlling for polydrug use.
Topics: Amphetamine-Related Disorders; Cognition; Cognition Disorders; Cross-Sectional Studies; Decision Mak | 2007 |
Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System; Cognition Disorders; Electroencephalog | 2005 |
Impulsivity, inhibition and negative priming in ecstasy users.
Topics: Adult; Cannabis; Cognition Disorders; Female; Humans; Impulsive Behavior; Inhibition, Psychological; | 2006 |
Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Cognition; Cognition Disorders; De | 2005 |
Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
Topics: Adult; Chronic Disease; Cognition Disorders; Female; Humans; Inhibition, Psychological; Male; Memory | 2006 |
Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Cognition; Cognition Disorders; Decision | 2007 |
MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Attention; Cocaine-Related Disorders; | 2006 |
Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects.
Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Blinking; Cognition; Cognition Disorders; Extra | 2006 |
Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
Topics: Amphetamine-Related Disorders; Amphetamines; Animals; Attention; Attention Deficit Disorder with Hyp | 2007 |
[Psychiatric illness associated with amphetamines and other stimulants].
Topics: Adult; Amnesia; Amphetamines; Central Nervous System Stimulants; Cognition Disorders; Designer Drugs | 2000 |
Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.
Topics: Adult; Analysis of Variance; Case-Control Studies; Cognition Disorders; Female; Humans; Male; Memory | 2007 |
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Topics: Adult; Attention; Cannabis; Cognition; Cognition Disorders; Cohort Studies; Female; Follow-Up Studie | 2007 |
Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
Topics: Adult; Case-Control Studies; Cognition Disorders; Hallucinogens; Humans; Illicit Drugs; Learning; Ma | 2007 |
Everyday memory deficits in ecstasy-polydrug users.
Topics: Adult; Cannabis; Cognition Disorders; Female; Hallucinogens; Humans; Illicit Drugs; Linear Models; M | 2007 |
DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.
Topics: Animals; Behavior, Animal; Cognition Disorders; Comet Assay; Disease Models, Animal; DNA Breaks, Dou | 2007 |
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Topics: Adolescent; Adult; Amphetamine; Attention; Cannabis; Central Nervous System Stimulants; Cocaine; Cog | 2008 |
Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
Topics: Adult; Cognition Disorders; Drug Synergism; Female; Follow-Up Studies; Hallucinogens; Humans; Illici | 2008 |
Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Topics: Adult; Affect; Attention; Cannabis; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional | 2008 |
Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.
Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Cognition Disorders; Control Groups; Decisio | 2008 |
Death by "ecstasy": the serotonin syndrome?
Topics: Adult; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Cognition Disorders; Epilepsy, Tonic | 1998 |
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Topics: Cognition Disorders; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Subst | 2000 |
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Topics: Adolescent; Adult; Attention; Cognition Disorders; Female; Hallucinogens; Humans; Intelligence; Lear | 2000 |
Does recreational ecstasy use cause long-term cognitive problems?
Topics: Animals; Cognition Disorders; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Neuroto | 2000 |
The relative contributions of ecstasy and cannabis to cognitive impairment.
Topics: Adolescent; Adult; Analysis of Variance; Cognition; Cognition Disorders; Dronabinol; Female; Halluci | 2001 |
Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
Topics: Adult; Cognition Disorders; Female; Hallucinogens; Humans; Intelligence Tests; Male; Mental Recall; | 2001 |
Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Topics: Adult; Analysis of Variance; Cognition Disorders; Female; Hallucinogens; Humans; Impulsive Behavior; | 2002 |
What is a dose of ecstasy?
Topics: Cognition Disorders; Dose-Response Relationship, Drug; Hallucinogens; Humans; N-Methyl-3,4-methylene | 2002 |
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?
Topics: 3,4-Methylenedioxyamphetamine; Adult; Cognition Disorders; Depressive Disorder; Female; Humans; Male | 1992 |